These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2116551)

  • 1. Glucose production rates in type 1 glycogen storage disease.
    Collins JE; Bartlett K; Leonard JV; Aynsley-Green A
    J Inherit Metab Dis; 1990; 13(2):195-206. PubMed ID: 2116551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose recycling and production in children with glycogen storage disease type I, studied by gas chromatography/mass spectrometry and (U-13C)glucose.
    Kalderon B; Lapidot A; Korman SH; Gutman A
    Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):305-8. PubMed ID: 3242682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Inherit Metab Dis; 1994; 17(2):234-41. PubMed ID: 7967479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous glucose production in Type I glycogen storage disease.
    Powell RC; Wentworth SM; Brandt IK
    Metabolism; 1981 May; 30(5):443-50. PubMed ID: 6939954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose production and utilization in children with glycogen storage disease type I.
    Tsalikian E; Simmons P; Gerich JE; Howard C; Haymond MW
    Am J Physiol; 1984 Oct; 247(4 Pt 1):E513-9. PubMed ID: 6388348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose recycling and production in glycogenosis type I and III: stable isotope technique study.
    Kalderon B; Korman SH; Gutman A; Lapidot A
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E346-53. PubMed ID: 2782400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose production in glycogen storage disease I is not associated with increased cycling through hepatic glycogen.
    Rother KI; Schwenk WF
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E774-8. PubMed ID: 7485494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal rate of enteral glucose administration in children with glycogen storage disease type I.
    Schwenk WF; Haymond MW
    N Engl J Med; 1986 Mar; 314(11):682-5. PubMed ID: 3081806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
    Stanley CA; Mills JL; Baker L
    Pediatr Res; 1981 Dec; 15(12):1504-8. PubMed ID: 6798537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence.
    Däublin G; Schwahn B; Wendel U
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S40-5. PubMed ID: 12373569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study.
    Weghuber D; Mandl M; Krssák M; Roden M; Nowotny P; Brehm A; Krebs M; Widhalm K; Bischof MG
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1378-84. PubMed ID: 17785500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of liver glycogenoses, with particular reference to the metabolism of intravenously administered glycerol.
    Senior B; Loridan L
    N Engl J Med; 1968 Oct; 279(18):958-65. PubMed ID: 4300572
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.
    Shah KK; O'Dell SD
    J Hum Nutr Diet; 2013 Aug; 26(4):329-39. PubMed ID: 23294025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulation of endogenous glucose production during hyperglucagonemia.
    Toft I; Gerich JE; Jenssen T
    Metabolism; 2002 Sep; 51(9):1128-34. PubMed ID: 12200756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal blood glucose concentrations: metabolic effects of intravenous glucagon and intragastric medium chain triglyceride.
    Hawdon JM; Aynsley-Green A; Ward Platt MP
    Arch Dis Child; 1993 Mar; 68(3 Spec No):255-61. PubMed ID: 8466259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.